Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate-Reference-Cited by-同舟云学术

Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate

Published:2011-09 Issue:1-3 Volume:667 Page:153-159
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Angulo Javier,Peiró Concepción,Romacho Tania,Fernández Argentina,Cuevas Begoña,González-Corrochano Rocío,Giménez-Gallego Guillermo,de Tejada Iñigo Sáenz,Sánchez-Ferrer Carlos F.,Cuevas Pedro

Publisher

Elsevier BV

Subject

Pharmacology

Reference57 articles.

1. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;N. Engl. J. Med.,1994

2. Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids;Allain;Drug Saf.,2004

3. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin. Possible mechanisms involved;Angulo;Hypertension,1996

4. Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins;Ashikari-Hada;J. Biol. Chem.,2005

5. Regulation of microvascular permeability by vascular endothelial growth factors;Bates;J. Anat.,2002

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study protocol for assessment of the efficacy of calcium dobesilate versus placebo on SARS-CoV-2 viral load in outpatients with COVID-19 (CADOVID study): a randomised, placebo-controlled, double-blind, monocentric phase II trial;BMJ Open;2024-05

2. Clinical application of calcium dobesilate in acute and sub-acute COVID-19: Two case reports;SAGE Open Medical Case Reports;2024-01

3. Enhancing identification and treatment of patients with concomitant chronic venous insufficiency and diabetes mellitus. A modified Delphi study from the CODAC (ChrOnic venous disease and Diabetes Advisory Council) group;International Angiology;2023-11

4. Evaluation of the effect of etamsylate on thromboelastographic traces of canine blood with and without the addition of heparin;Veterinary Quarterly;2023-09-16

5. Effects of Calcium Dobesilate on Inner Retinal Thickness in Severe Non-proliferative Diabetic Retinopathy;Annals of Optometry and Contact Lens;2023-06-25